Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: A randomized cross-over trial

Diabetes, Obesity and Metabolism

Volumn 18, Issue 2, 2016, Pages 196-199

  Heise, T ^a   Bain, S C ^b   Bracken, R M ^b   Zijlstra, E ^a   Nosek, L ^a   Stender Petersen, K ^c   Rabol R ^c   Rowe, E ^d   Haahr, H L ^c  

^a Profil   (Germany)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

^d NOVO NORDISK INC   (United States)

Author keywords

Exercise; Glycaemic control; Insulin therapy; Type 1 diabetes

Indexed keywords

GLUCOSE; HORMONE; INSULIN DEGLUDEC; INSULIN GLARGINE; ANTIDIABETIC AGENT; INSULIN ASPART; LONG ACTING INSULIN;

ADULT; ADVERSE OUTCOME; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG SAFETY; ERGOMETER; EXERCISE; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STEADY STATE; ADOLESCENT; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; EXERCISE TEST; HYPERGLYCEMIA; MIDDLE AGED; MOTOR ACTIVITY; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN ASPART; INSULIN GLARGINE; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; MOTOR ACTIVITY; RISK; YOUNG ADULT;

EID: 84956918567     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12588     Document Type: Letter

References (15)

1. West DJ, Morton RD, Bain SC, Stephens JW, Bracken RM. Blood glucose responses to reductions in pre-exercise rapid-acting insulin for 24h after running in individuals with type 1 diabetes. J Sports Sci 2010; 28: 781-788.
2. Metcalf KM, Singhvi A, Tsalikian E etal. Effects of moderate-to-vigorous intensity physical activity on overnight and next-day hypoglycemia in active adolescents with type 1 diabetes. Diabetes Care 2014; 37: 1272-1278.
3. Riddell MC, Perkins BA. Type 1 diabetes and vigorous exercise: applications of exercise physiology to patient management. Can J Diabetes 2006; 30: 63-71.
4. DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 1981; 68: 1468-1474.
5. Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H. Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 2008; 31: 2108-2109.
6. Perry E, Gallen IW. Guidelines on the current best practice for the management of type 1 diabetes, sport and exercise. Pract Diab Int 2009; 26: 116-123.
7. West DJ, Stephens JW, Bain SC etal. A combined insulin reduction and carbohydrate feeding strategy 30-ámin before running best preserves blood glucose concentration after exercise through improved fuel oxidation in type 1 diabetes mellitus. J Sports Sci 2010; 29: 279-289.
8. Campbell MD, Walker M, Trenell MI etal. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care 2013; 36: 2217-2224.
9. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Last amended by the 59th WMA General Assembly, Seoul, 2008.
10. International Conference on Harmonisation (ICH) Harmonised tripartite guideline: guideline for good clinical practice E6 (R1), Step 4. 10 June 1996.
11. The IPAQ Group. Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) - Short and Long Forms. 2005. Available from URL: https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnx0aGVpcGFxfGd4OjE0NDgxMDk3NDU1YWRlZTM. Accesssed 30 October 2015.
12. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983; 55: 628-634.
13. Heller SR, Gough SCL, Oyer DS, Jensen KH, Kinduryte O, Philis-Tsimikas A. Exercise-related hypoglycemia occurs at similar frequency with insulin degludec and insulin glargine (Abstract). Diabetes 2013; 62(Suppl. 1): A187.
14. American Diabetes Association. Medical Management of Type 1 Diabetes. Alexandria, VA: American Diabetes Association, 2008.
15. Heise T, Hövelmann U, Nosek L, Hermanski L, Bøttcher SG, Haahr H. Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine. Expert Opin Drug Metab Toxicol 2015; 11: 1193-1201.